Surfactin Mitigates a High-Fat Diet and Streptozotocin-Induced Type 2 Diabetes through Improving Pancreatic Dysfunction and Inhibiting Inflammatory Response

Surfactin from Bacillus amyloliquefaciens fmb50 was utilized to treat mice with type 2 diabetes (T2DM) induced by a high-fat diet/streptozotocin (HFD/STZ). Our group’s earlier research indicated that surfactin could lower blood glucose and mitigate liver dysfunction to further improve HFD/STZ-induce...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xiaoyu, Zhao, Hongyuan, Lu, Yajun, Liu, Huawei, Meng, Fanqiang, Lu, Zhaoxin, Lu, Yingjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570334/
https://www.ncbi.nlm.nih.gov/pubmed/36232419
http://dx.doi.org/10.3390/ijms231911086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570334/
https://www.ncbi.nlm.nih.gov/pubmed/36232419
http://dx.doi.org/10.3390/ijms231911086

Ejemplares similares